Han Weiping Lab @ IMCB
Invitation for Participation
21st – 22nd November 2022, 9am - 5:30pm
Multi-purpose Halls 1&2, Innovis, 2 Fusionopolis Way, Singapore 138634
The Institute of Molecular and Cell Biology (IMCB) under the Agency for Science, Technology and Research (A*STAR) and Duke-NUS Medical School invite you to the 2022 Singapore Symposium on Metabolic Diseases/Asia-Pacific Diabetes and Obesity Study Group Annual Conference.
Inaugurated in 2007 and held annually, the symposium has been a forum to bring together world experts in the broad areas of diabetes, obesity and metabolic diseases to share their latest research findings and insights. The event also serves as a platform for the invited speakers and participants to meet and forge collaborations with local scientists. This year, it is a joint symposium with the Asia-Pacific Diabetes and Obesity Study Group (APDO) Annual Conference. APDO is an international forum organized by leading scientists in the research areas of metabolic diseases and associated complications from the Asia-Pacific region. We have 25 speakers from overseas and 10 speakers from local research organizations for this year’s event. The topics to be discussed at the symposium will span from basic science to clinical research and cover research topics in neuroscience, lipid and adipose tissue biology and metabolic diseases.
Pei Duanqing (Westlake Univ.), David James (University of Sydney), Kim Jae Bum (Seoul National Univ.), Xu Aimin (Hong Kong Univ.), Iichiro Shimomura (Osaka Univ.), Wataru Ogawa (Kobe Univ.), Kojiro Ueki (National Center for Global Health and Medicine), Peter Shepherd (University of Auckland), Guan Youfei (Dalian Medical University), Zhang Weiping (Navy Medical University), Li Wen-Hong (UT Southwestern), Yang Xiaoyong (Yale), Christian Wolfrum (ETH Zurich) etc.
Tom Coffman (Duke-NUS), Sun Lei (Duke-NUS), Paul Yen (Duke-NUS), Jacques Behmoaras (Duke-NUS), Markus Wenk (NUS), Tan Hong Chang (SGH), Fu Yu (IMCB), Sarah Luo (IMCB), Caroline Wee (IMCB).
The symposium is co-organized by the Brain-Body Initiative (BBI), A*STAR.
Click HERE for more details on the 2022 SSMD/APDO
For more details, please contact XING Xing: firstname.lastname@example.org